Related Experiment Video
Updated: Jan 27, 2026

Identification of Coding and Non-coding RNA Classes Expressed in Swine Whole Blood
Published on: November 28, 2018
Long Non-Coding RNA in Vascular Disease and Aging
Diewertje I Bink1, Noelia Lozano-Vidal2, Reinier A Boon3,4,5
1Department of Physiology, Amsterdam Cardiovascular Sciences, Amsterdam UMC, VU University, 1081HV Amsterdam, The Netherlands. d.bink1@vumc.nl.
Insights
Long non-coding RNAs (lncRNAs) offer new therapeutic targets for cardiovascular diseases, which are a leading cause of death, particularly in the elderly. This review explores lncRNAs involved in vascular disease and aging for potential diagnostic and therapeutic strategies.
Area of Science:
- Biomedical research
- Molecular biology
- Genetics
Background:
- Cardiovascular diseases (CVDs) are the primary cause of mortality in Western nations, disproportionately affecting the elderly population.
- Increasing life expectancy is projected to exacerbate the prevalence of CVDs, intensifying the healthcare burden.
- Novel therapeutic strategies are urgently needed to address the growing number of patients with cardiovascular conditions.
Purpose of the Study:
- To review the role of long non-coding RNAs (lncRNAs) in vascular disease and aging.
- To identify potential diagnostic, preventive, and therapeutic targets within lncRNA pathways.
- To provide insights into novel molecular mechanisms underlying cardiovascular conditions.
Main Methods:
- Literature review of studies on lncRNAs in vascular disease and aging.
- Analysis of lncRNA regulation in the context of cardiovascular health and disease.
- Identification of lncRNAs implicated in age-related vascular changes.
Main Results:
- Long non-coding RNAs are emerging as key regulators in vascular disease and aging processes.
- Specific lncRNAs show altered expression patterns associated with vascular pathologies and senescence.
- These lncRNAs represent a novel class of molecules with therapeutic potential.
Conclusions:
- Long non-coding RNAs are promising candidates for developing new diagnostic and therapeutic interventions for cardiovascular diseases.
- Targeting lncRNAs may offer novel pathways to combat vascular disease and mitigate aging-related cardiovascular decline.
- Further research into lncRNA function is crucial for advancing cardiovascular medicine.
Abstract:
Cardiovascular diseases are the most prominent cause of death in Western society, especially in the elderly. With the increasing life expectancy, the number of patients with cardiovascular diseases will rise in the near future, leading to an increased healthcare burden. There is a need for new therapies to treat this growing number of patients. The discovery of long non-coding RNAs has led to a novel group of molecules that could be considered for their potential as therapeutic targets. This review presents an overview of long non-coding RNAs that are regulated in vascular disease and aging and which might therefore give insight into new pathways that could be targeted to diagnose, prevent, and/or treat vascular diseases.
Related Concept Videos
lncRNA - Long Non-coding RNAs
lncRNA - Long Non-coding RNAs
RNA Splicing
Ribosomal RNA Synthesis
Ribosome biogenesis begins with the synthesis of 5S and 45S pre-rRNAs by distinct RNA polymerases. The primary transcripts are extensively processed and modified before they are bound and folded by ribosomal proteins and assembly factors,...
Nursing Code of Ethics
Aging
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...

